Ann: Response to ASX Query, page-7

MGC Pharmaceuticals wins food supplement import approval in India,

Have to say that this now spells out where MXC has fallen to as a company. It used to aim at being a major supplier of Medical Cannabis and supplier of cannabis based medicines.

Today, a shadow of itself aiming at a low risk fringe market. Certainly, in my view anyway, has lost its way and seems to be having difficulty in maintaining focus on its goals - and I am not sure what those goals are these days. Bit sad really.

This is a major disappointment to past holders - and maybe current holders as well - or, at least, should be. It all seems to be unravelling now for MXC.